Core One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-08-17. The firm is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. The company is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. The company also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.
Follow-Up Questions
Core One Labs Inc의 CEO는 누구입니까?
Mr. Joel Shacker은 2020부터 회사에 합류한 Core One Labs Inc의 Chief Executive Officer입니다.
CLABF 주식의 가격 성능은 어떻습니까?
CLABF의 현재 가격은 $0.0001이며, 전 거래일에 decreased 0% 하였습니다.
Core One Labs Inc의 주요 사업 주제나 업종은 무엇입니까?
Core One Labs Inc은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
